NORD: IgA Nephropathy (Premium & Copay)
Funded
About
The NORD: IgA Nephropathy (Premium & Copay) program assists patients with the financial burdens of IgA Nephropathy treatment, offering support for insurance premiums and copays. The program covers several drug products including Rayos, Betamethasone Sodium Phosphate & Betamethasone Acetate, Jardiance, Tarpeyo, Filspari, and Fabhalta, making treatment more accessible for eligible patients.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
NORD: IgA Nephropathy (Premium & Copay)
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note the following:
•1. Program offers assistance with insurance copays and premiums only
•2. Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program
•3. Specialty Pharmacy representatives/case managers can send new referrals through the referral portal (https://rareaccess.org/#/login). Representatives must be preregistered by sending a request to RareAccess@rarediseases.org. Representatives can also email the program email address. To make the problem resolution quicker and more efficient please do not send messages to individual emails. If the matter is URGENT, please reach out to SP account manager for NORD to escalate the issue
•Patients may apply online, call (2033093276) or email (IGAnephropathy@rarediseases.org) program to enroll
•Awards are made for a calendar year, and patients may reapply for subsequent years
•NORD is able to offer same day approval for programs
•Patients must undergo a financial evaluation of need, and provide HIPPA authorization and accept a waiver of liability
•Fax number for program is 4752060857
Enrollment Forms
Enrollment Form
Other Programs